KALA
KALA BIODNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
KALA vs peer average
55/100
KALA vs. peer average (D vs. D)
Grade spread
B 1 · C 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ACTU is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $44.98M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KALA
KALA BIO
ACTU
Actuate Therapeutics
Grade
D
N/A
Momentum
39
30
Value
41
-
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Unrated
Grade position vs ACTU
KALA / ACTU
Grade Position
In line
KALA vs. peer average (D vs. D)
55/100
Momentum
39
KALAValue
41
-Sentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KALA
ACTU is the first peer returned for this comparison set.

